Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Esophageal Ulceration after Taking Doxycycline

독시사이클린 복용 후 발생한 식도궤양형성 사례

  • Kim, Ga Yeon (College of Pharmacy, Gachon University) ;
  • Lee, Chan Hee (College of Pharmacy, Gachon University) ;
  • Lee, Jeong Woo (College of Pharmacy, Gachon University) ;
  • Lee, Jung-Min (Regional Pharmacovigilance Center, Korean Pharmaceutical Association) ;
  • Lee, Mo-Se (Regional Pharmacovigilance Center, Korean Pharmaceutical Association) ;
  • Ji, Eunhee (College of Pharmacy, Gachon University)
  • 김가연 (가천대학교 약학대학) ;
  • 이찬희 (가천대학교 약학대학) ;
  • 이정우 (가천대학교 약학대학) ;
  • 이정민 (대한약사회 지역의약품안전센터) ;
  • 이모세 (대한약사회 지역의약품안전센터) ;
  • 지은희 (가천대학교 약학대학)
  • Received : 2019.04.29
  • Accepted : 2019.06.26
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Doxycycline is frequently prescribed to treat urogenital infections or acne vulgaris. A 39-year-old man was prescribed doxycycline as a treatment for his skin infection. He took each tablet on an empty stomach in the morning, and just before going to bed with insufficient water. After taking the prescribed medication for approximately 3 weeks, he was diagnosed with esophageal ulcer. He had not experienced these symptoms before, and the drug label says that doxycycline rarely causes esophageal ulcer. After discontinuing the medication, the symptoms disappeared. Using the World Health Organization-Uppsala Monitoring Center criteria, the causality for doxycycline-induced esophageal ulcer was evaluated as "possible." Additionally, using the Naranjo scale and Korean causality assessment algorithm (Ver. 2), the causality was evaluated as "probable." Previous reports have stated that most patients who took doxycycline with insufficient water just before going to bed or in the supine position developed esophageal ulcer. Therefore, all patients taking doxycycline must be provided with detailed instructions about the appropriate administration methods.

Keywords

References

  1. Ministry of Food and Drug Safety. Integrated medicine information system: doxycycline. Available from https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetail?itemSeq=198000105. Accessed March 11, 2019.
  2. Kadayifci A, Gulsen MT, Koruk M, et al. Doxycycline-induced pill esophagitis. Dis Esophagus 2004;17(2):168-71. https://doi.org/10.1111/j.1442-2050.2004.00384.x
  3. Korea Pharmaceutical Information Center. Available from http://bitly.kr/DCBZX. Accessed March 28, 2019.
  4. Micromedex. Doxycycline dosing/administration. Available from http://bitly.kr/KAQ0j. Accessed March 27, 2019.
  5. Al-Mofarreh MA and Al Mofleh IA. Esophageal ulceration complicating doxycycline therapy. World J Gastroenterol 2003;9(3):609-11. https://doi.org/10.3748/wjg.v9.i3.609
  6. Zografos GN, Georgiadou D, Thomas D, et al. Drug-induced esophagitis. Dis Esophagus 2009;22(8):633-7. https://doi.org/10.1111/j.1442-2050.2009.00972.x
  7. Sasaki Y, Suzuki T, Zai H, et al. Esophageal ulcer associated with inappropriately taken doxycycline: A benign mimicker of esophageal cancer. J Gen Fam Med 2017;18(4):171-2. https://doi.org/10.1002/jgf2.55
  8. Del Rosso JQ. Oral doxycycline in the management of acne vulgaris: current perspectives on clinical use and recent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol 2015;8(5):19-26.
  9. Kikendall JW, Friedman AC, Oyewole MA, et al. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci 1983;28(2):174-82. https://doi.org/10.1007/BF01315148
  10. Carlborg B, Densert O, Lindqvist C. Tetracycline induced esophageal ulcers. a clinical and experimental study. Laryngoscope 1983;93(2):184-7.
  11. World Health Organization (WHO) - Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. Available from https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf. Accessed June 17, 2019.
  12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45. https://doi.org/10.1038/clpt.1981.154
  13. Hong K, Park B, Sin S, et al. Development of a Korean algorithm for causality assessment of adverse drug reactions. J Kor Soc Clin Pharmacol Ther 2002;10(10):129-42. https://doi.org/10.12793/jkscpt.2002.10.2.129
  14. Ministry of Food and Drug Safety. Integrated medicine information system: methylprednisolone. Available from https://nedrug.mfds. go.kr/pbp/CCBBB01/getItemDetail?itemSeq=199701131. Accessed June 19, 2019.
  15. Dag MS, Ozturk ZA, Akin I, et al. Drug-induced esophageal ulcers: case series and the review of the literature. Turk J Gastroenterol 2014;25(2):180-4. https://doi.org/10.5152/tjg.2014.5415
  16. Segelnick SL and Weinberg MA. Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review. J Am Dent Assoc 2008;139(5):581-5. https://doi.org/10.14219/jada.archive.2008.0218
  17. Tahan V, Sayrak H, Bayar N, et al. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J 2008;1(1):144. https://doi.org/10.1186/1757-1626-1-144
  18. Shih AR, Lauwers GY, Mattia A, et al. Vascular injury characterizes doxycycline-induced upper gastrointestinal tract mucosal injury. Am J Surg Pathol 2017;41(3):374-81. https://doi.org/10.1097/PAS.0000000000000792
  19. Medlicott SA, Ma M, Misra T, et al. Vascular wall degeneration in doxycycline-related esophagitis. Am J Surg Pathol 2013;37(7):1114-5. https://doi.org/10.1097/PAS.0b013e31828f5a3f
  20. Xiao SY, Zhao L, Hart J, et al. Doxycycline-induced gastric and esophageal mucosal injuries with vascular degeneration. Am J Surg Pathol 2013;37(7):1115-6. https://doi.org/10.1097/PAS.0b013e31828f5b3a
  21. Lee CZ, Yao JS, Huang Y, et al. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab 2006;26(9):1157-64. https://doi.org/10.1038/sj.jcbfm.9600268
  22. Kikendall JW. Pill esophagitis. J Clin Gastroenterol 1999;28(4):298-305. https://doi.org/10.1097/00004836-199906000-00004
  23. Morris TJ and Davis TP. Doxycycline-induced esophageal ulceration in the U.S. military service. Mil Med 2000;165(4):316-9. https://doi.org/10.1093/milmed/165.4.316
  24. Ovartlarnporn B, Kulwichit W, Hiranniramol S. Medication-induced esophageal injury: report of 17 cases with endoscopic documentation. Am J Gastroenterol 1991;86(6):748-50.
  25. Skinner DB and Belsey RH. Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients. J Thorac Cardiovasc Surg 1967;53(1):33-54. https://doi.org/10.1016/S0022-5223(19)43239-X
  26. O'Meara TF. A new endoscopic finding of tetracycline-induced esophageal ulcers. Gastrointest Endosc 1980;26(3):106-7. https://doi.org/10.1016/S0016-5107(80)73288-1
  27. Chandy G and Rolston DD. Doxycycline-induced esophageal ulceration: do old capsules play a role?. J Clin Gastroenterol 1987;9(1):113. https://doi.org/10.1097/00004836-198702000-00029
  28. Leber A and Stal J. Simultaneous esophageal and gastric ulceration due to doxycycline ingestion: Case report and review of the literature. Gastroenterology Res 2012;5(6):236-8.
  29. Shelat VG, Seah M, Lim KH. Doxycycline induced acute erosive oesophagitis and presenting as acute dysphagia. J Assoc Physicians India 2011;59:57-9.